Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)
RecruitingOBSERVATIONAL
Enrollment
52
Participants
Timeline
Start Date
March 15, 2024
Primary Completion Date
March 15, 2027
Study Completion Date
March 15, 2027
Conditions
Pleural Mesothelioma Malignant
Trial Locations (1)
33081
RECRUITING
Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS, Aviano